Clinical Trial Update: NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating oral NBM-BMX in patients with solid tumors or newly diagnosed glioblastoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Glioblastoma

Drugs mentioned

• NBM-BMX

Snippet

Sponsor: Novelwise Pharmaceutical Corporation | Conditions: Malignant Neoplasm, Malignant Neoplasm of Brain | Phase 1, Phase 2 | Status: RECRUITING